• Supply 99% API Powder Antineoplastic Iressa CAS 184475-35-2 Gefitinib
  • Supply 99% API Powder Antineoplastic Iressa CAS 184475-35-2 Gefitinib
  • Supply 99% API Powder Antineoplastic Iressa CAS 184475-35-2 Gefitinib
  • Supply 99% API Powder Antineoplastic Iressa CAS 184475-35-2 Gefitinib
  • Supply 99% API Powder Antineoplastic Iressa CAS 184475-35-2 Gefitinib
  • Supply 99% API Powder Antineoplastic Iressa CAS 184475-35-2 Gefitinib

Supply 99% API Powder Antineoplastic Iressa CAS 184475-35-2 Gefitinib

Powder: Yes
Customized: Non-Customized
Certification: GMP, ISO 9001, USP, BP
Suitable for: Elderly, Adult
State: Solid
Purity: >99%
Samples:
US$ 1/gram 1 gram(Min.Order)
| Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Trading Company

Basic Info.

CAS No.
184475-35-2
Appearance
White Powder
Einecs
616-396-9
Assay
99%
Shelf
2 Years
Transport Package
25kg/Drum1g, 50g, 500g, 1kg, 10kg, 100kg, 200kg
Specification
25kg/drum
Trademark
tongyon
Origin
China
Production Capacity
5000kg/Month

Product Description

Supply 99% API Powder Antineoplastic Iressa CAS 184475-35-2 Gefitinib
Supply 99% API Powder Antineoplastic Iressa CAS 184475-35-2 Gefitinib

Supply 99% API Powder Antineoplastic Iressa CAS 184475-35-2 Gefitinib
 
Product name Gefitinib
CAS 184475-35-2
Appearance white powder
Assay 99%
Storage Cool and Protect from light


Supply 99% API Powder Antineoplastic Iressa CAS 184475-35-2 Gefitinib

Product Name:Gefitinib
CAS:184475-35-2
MF:C22H24ClFN4O3
MW:446.9
EINECS:643-034-7
Mol File:184475-35-2.mol    
Melting point:119-1200C
Boiling point:586.8±50.0 °C(Predicted)
Density 1.322±0.06 g/cm3(Predicted)
storage temp. Store at RT
pka7.00±0.10(Predicted)
form powder
color white to beige




Supply 99% API Powder Antineoplastic Iressa CAS 184475-35-2 Gefitinib


Description

Gefitinib is an antineoplastic target therapy drug with relatively high specificity that was developed by the British pharmaceutical company AstraZeneca; it is the first molecular targeted drug to be used in non-small cell lung cancer treatment. Epidermal growth factors (EGF) are a kind of polypeptide with a relative molecular mass of 6.45x103, and they can bind with epidermal growth factor receptors (EGFR) on target cell membrane surfaces to trigger biological effects. EGFR is a type of tyrosine kinase (TK) type receptor, so when bound with EGF, it will promote TK activation in the receptor. This will cause tyrosine residue in the receptor to autophosphorylate and send continuous dividing signals into the cell, causing cell proliferation and differentiation. EGFR is abundant in human tissue, and it is highly expressed in malign tumors. Gefitinib blocks the signal transduction pathway of cell surface EGFR to prevent tumor growth, metastasis, and growth in blood vessels, and it can induce tumor cell apoptosis. Gefitinib is mainly used to treat non-stem cell lung cancer.

GuangZhou TongYi biochemistry technology Co., Ltd is a company specializing in active pharmaceutical ingredient
(API), biology, plant extracts, chemical raw materials, fine chemicals, pharmaceutical intermediates, cosmetics raw
material. Our company has always adhered to the company phi
osophy of integrity, professionalism, quality first, and
customer service. With the efforts of all the company's employees, it has established long-term
and stable cooperative relations with many domestic and foreign customers, and won the unanimous trust of domestic
and foreign customers. With good comments, our company have made great progress.


Our company takes pioneering and innovative, high-quality and efficient as the code of conduct, and strives to provide
customers with efficient services,
high-quality products, and reasonable prices. We have established a customer demand-oriented, flexible, diverse and customizable service according to the different needs of different customers. Mode, and ultimately achieve the goal of
win-win.


Our company focuses on the future and the world, and will continue to devote itself to technological progress and the
development of new products in the future, hoping to work hand in hand with new and old friends at home and abroad
to create a better future.


Supply 99% API Powder Antineoplastic Iressa CAS 184475-35-2 GefitinibSupply 99% API Powder Antineoplastic Iressa CAS 184475-35-2 GefitinibSupply 99% API Powder Antineoplastic Iressa CAS 184475-35-2 GefitinibSupply 99% API Powder Antineoplastic Iressa CAS 184475-35-2 GefitinibSupply 99% API Powder Antineoplastic Iressa CAS 184475-35-2 Gefitinib

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2021

Suppliers with verified business licenses

Trading Company
Number of Employees
2
Year of Establishment
2017-08-08